Organon & Co. logo

Organon & Co. Share Price Today (NYSE: OGN)

Organon & Co. share price is $8.53 & ₹729.52 as on 22 May 2025, 2.30 'hrs' IST

$8.53

-0.23

(-2.63%)

Live

View live Organon & Co. share price in Dollar and Rupees. Guide to invest in Organon & Co. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Organon & Co., along with analyst recommendations, forecasts, and comprehensive financials.

Organon & Co. share price movements

  • Today's Low: $8.36
    Today's High: $8.61

    Day's Volatility :2.86%

  • 52 Weeks Low: $8.01
    52 Weeks High: $23.10

    52 Weeks Volatility :65.32%

Organon & Co. (OGN) Returns

PeriodOrganon & Co.Sector (Health Care)Index (Russel 2000)
3 Months
-42.71%
-8.0%
0.0%
6 Months
-40.53%
-6.4%
0.0%
1 Year
-59.91%
-7.8%
0.0%
3 Years
-76.66%
3.8%
-0.2%

Organon & Co. (OGN) Key Statistics

in dollars & INR

Previous Close
$8.76
Open
$8.67
Today's High
$8.61
Today's Low
$8.3093
Market Capitalization
$2.3B
Today's Volume
$5.3M
52 Week High
$23.1
52 Week Low
$8.01
Revenue TTM
$6.3B
EBITDA
$1.7B
Earnings Per Share (EPS)
$2.88
PE Ratio
3.13
Dividend Yield
0.89%
Profit Margin
11.92%
Quarterly Earnings Growth YOY
-0.58%
Return On Equity TTM
254.24%

How to invest in Organon & Co. Stock (OGN) from India?

It is very easy for Indian residents to invest directly in Organon & Co. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Organon & Co. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Organon & Co. or OGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Organon & Co. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Organon & Co. shares which would translate to 0.100 fractional shares of Organon & Co. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Organon & Co., in just a few clicks!

Returns in Organon & Co. (OGN) for Indian investors in Rupees

The Organon & Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Organon & Co. investment value today

Current value as on today

₹41,721

Returns

₹58,279

(-58.28%)

Returns from Organon & Co. Stock

₹60,961 (-60.96%)

Dollar Returns

₹2,682 (+2.68%)

Indian investors sentiment towards Organon & Co. (OGN)

1000.0%

Period: Apr 20, 2025 to May 20, 2025. Change in 30 Days versus previous period

Investment in Organon & Co. Shares from India has grown by 1000.0% over the past 30 days, indicating increased transactional activity.

123%

Period: Apr 20, 2025 to May 20, 2025. Change in 30 Days versus previous period

Search interest for Organon & Co. Stock from India on INDmoney has increased by 123% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Organon & Co.

  • BlackRock Inc

    12.26%

  • Vanguard Group Inc

    11.43%

  • Pacer Advisors, INC.

    4.29%

  • Massachusetts Financial Services Company

    4.12%

  • State Street Corp

    3.45%

  • LSV Asset Management

    3.07%

Analyst Recommendation on Organon & Co.

Rating
Trend

Buy

    50%Buy

    42%Hold

    7%Sell

Based on 14 Wall street analysts offering stock ratings for Organon & Co.(by analysts ranked 0 to 5 stars)

Analyst Forecast on Organon & Co. Stock (OGN)

What analysts predicted

Upside of 89.53%

Target:

$16.17

Current:

$8.53

Insights on Organon & Co. Stock (Ticker Symbol: OGN)

  • Price Movement

    In the last 7 days, OGN stock has moved up by 9.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.59B → 1.51B (in $), with an average decrease of 5.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 359.0M → 87.0M (in $), with an average decrease of 44.9% per quarter
  • OGN vs ABBV (1 yr)

    In the last 1 year, Abbvie Inc has given 13.5% return, outperforming this stock by 73.4%
  • OGN vs LLY (3 yr)

    In the last 3 years, Eli Lilly And Company has given 22.4% return, outperforming this stock by 99.1%
  • Price to Sales

    ForOGN every $1 of sales, investors are willing to pay $0.4, whereas for Abbvie Inc, the investors are paying $5.7 for every $1 of sales.

Organon & Co. Technicals Summary

Sell

Neutral

Buy

Organon & Co. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Organon & Co. (OGN) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Organon & Co. logo
-17.59%
-40.53%
-59.91%
-76.66%
-75.67%
Eli Lilly And Company logo
-8.67%
-0.84%
-6.98%
146.88%
394.22%
Johnson & Johnson logo
-2.11%
0.33%
1.57%
-14.39%
6.4%
Merck & Co. Inc. logo
0.16%
-19.98%
-40.37%
-16.9%
2.1%
Novo Nordisk A/s logo
16.94%
-35.2%
-49.53%
26.5%
110.43%
Abbvie Inc logo
8.64%
10.2%
13.47%
24.89%
100.73%

Organon & Co. Dividend announcements

  • Organon & Co. Dividends June, 2025

    In the quarter ending June,2025. Organon & Co. has declared dividend of $0.02

About Organon & Co.

Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon, which are daily pills used to prevent pregnancy; Follistim AQ, which is used to promote the development of multiple ovarian follicles in medically assisted reproduction procedures; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding or hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products used to control and prevent asthma-induced symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company sells its products to drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.
Organization
Organon & Co.
Employees
10000
CEO
Mr. Kevin Ali
Industry
Healthcare

Management People of Organon & Co.

NameTitle
Mr. Kevin Ali
CEO & Director
Mr. Matthew M. Walsh C.F.A.
Executive VP & CFO
Mr. Joseph T. Morrissey Jr.
Executive VP and Head of Manufacturing & Supply
Dr. Juan Camilo Arjona Ferreira M.D.
Executive VP, Head of Research & Development and Chief Medical Officer
Mr. Kirke Weaver
Executive VP, General Counsel & Corporate Secretary
Ms. Rebecca Lowell Edwards
Chief Communications Officer
Mr. Daniel Karp
Head of Corporate Development
Mr. Aaron Falcione
Executive VP & Chief Human Resources Officer
Mr. Vittorio Nisita
Executive VP & Head of Enterprise Services and Solutions
Ms. Rachel A. Stahler
Chief Digital & Commercial Innovation Officer

Important FAQs about investing in OGN Stock from India :

Can Indians buy Organon & Co. shares?

Yes, Indians can invest in the Organon & Co. (OGN) from India.

With INDmoney, you can buy Organon & Co. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Organon & Co. at zero transaction cost.

How can I buy Organon & Co. shares from India?

It is very easy to buy Organon & Co. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Organon & Co. (OGN) be purchased?

Yes, you can buy fractional shares of Organon & Co. with INDmoney app.

What are the documents required to start investing in Organon & Co. stocks?

To start investing in Organon & Co., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Organon & Co. share price today?

Organon & Co. share price today stands at $8.53, Open: $9.04 ; Previous Close: $8.76 ; High: $8.61 ; Low: $8.36 ; 52 Week High: $23.10 ; 52 Week Low: $8.01.

The stock opens at $9.04, after a previous close of $8.76. The stock reached a daily high of $8.61 and a low of $8.36, with a 52-week high of $23.10 and a 52-week low of $8.01.

What are today’s High and Low prices of Organon & Co. Stock (OGN)?

Today’s highest price of Organon & Co. (OGN) is $8.61.

Today’s lowest price of Organon & Co. (OGN) is $8.36.

What is the 52 Week High and Low Range of Organon & Co. Stock (OGN)?

  • 52 Week High

    $23.10

  • 52 Week Low

    $8.01

What are the historical returns of Organon & Co. (OGN)?

  • 1 Month Returns

    -17.59%

  • 3 Months Returns

    -40.53%

  • 1 Year Returns

    -59.91%

  • 5 Years Returns

    -75.67%

What is today's market capitalisation of Organon & Co.?

Today's market capitalisation of Organon & Co. OGN is 2.3B

Who is the Chief Executive Officer (CEO) of Organon & Co. ?

Mr. Kevin Ali is the current Chief Executive Officer (CEO) of Organon & Co..

Discover More